Combination ibandronate and radiotherapy for the treatment of bone metastases: Clinical evaluation and radiologic assessment

doi:10.1016/j.ijrobp.2006.08.022

Title: Combination ibandronate and radiotherapy for the treatment of bone metastases: Clinical evaluation and radiologic assessment

Full Record
Other Related Research

Abstract

Purpose: Ibandronate is a single-nitrogen, noncyclic bisphosphonate with proven efficacy for reducing metastatic bone pain. In this study, we assessed the palliative effects of combined ibandronate and radiotherapy. Methods and Materials: Forty-five patients with bone metastases from various solid tumors received external-beam radiotherapy, 30-40 Gy over 3-4.5, weeks combined with 10 cycles of monthly intravenous ibandronate, 6 mg. Results: After combined therapy, mean bone pain scores (graded from 0 to 10) were reduced from 6.3 at baseline to 0.8 after 3 months, with further reductions at later time points (all p < 0.001). Opioid use decreased from 84% of patients at baseline (38/45) to 24% (11/45) at 3 months, with further subsequent reductions (all p < 0.001). Mean performance status and functioning scores also significantly improved. Bone density (assessed by computed tomography scan) increased by 20% vs. baseline at 3 months, 46% at 6 months, and 73% at 10 months (all p < 0.001). Lesion improvement was also demonstrated by magnetic resonance imaging. Treatment was well tolerated with no renal toxicity. Conclusions: In this pilot study, combined radiotherapy and ibandronate provided substantial bone pain relief and increased bone density. Computed tomography-based or magnetic resonance imaging-based evaluations offer objective methods formore » assessing therapeutic outcomes.« less

Authors:

Vassiliou, Vassilios ^[1]; Kalogeropoulou, Christine ^[2]; Christopoulos, Christos ^[1]; Solomou, Ekaterini ^[2]; Leotsinides, Michael ^[3]; Kardamakis, Dimitrios ^[4]

Department of Radiotherapy, University of Patras Medical School, Patras (Greece)
Department of Radiology, University of Patras Medical School, Patras (Greece)
Laboratory of Public Health, University of Patras Medical School, Patras (Greece)
Department of Radiotherapy, University of Patras Medical School, Patras (Greece). E-mail: kardim@med.upatras.gr

Publication Date:: Mon Jan 01 00:00:00 EST 2007

OSTI Identifier:: 20850324

Resource Type:: Journal Article

Resource Relation:: Journal Name: International Journal of Radiation Oncology, Biology and Physics; Journal Volume: 67; Journal Issue: 1; Other Information: DOI: 10.1016/j.ijrobp.2006.08.022; PII: S0360-3016(06)02755-6; Copyright (c) 2007 Elsevier Science B.V., Amsterdam, Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA)

Country of Publication:: United States

Language:: English

Subject:: 62 RADIOLOGY AND NUCLEAR MEDICINE; COMBINED THERAPY; COMPUTERIZED TOMOGRAPHY; EVALUATION; METASTASES; NEOPLASMS; NMR IMAGING; PAIN; PATIENTS; PERFORMANCE; RADIOTHERAPY; SKELETON; TOXICITY

Citation Formats


                    Vassiliou, Vassilios, Kalogeropoulou, Christine, Christopoulos, Christos, Solomou, Ekaterini, Leotsinides, Michael, and Kardamakis, Dimitrios. Combination ibandronate and radiotherapy for the treatment of bone metastases: Clinical evaluation and radiologic assessment.  United States: N. p., 2007. 
        Web.  doi:10.1016/j.ijrobp.2006.08.022.

Copy to clipboard


                    Vassiliou, Vassilios, Kalogeropoulou, Christine, Christopoulos, Christos, Solomou, Ekaterini, Leotsinides, Michael, & Kardamakis, Dimitrios. Combination ibandronate and radiotherapy for the treatment of bone metastases: Clinical evaluation and radiologic assessment.  United States.  doi:10.1016/j.ijrobp.2006.08.022.

Copy to clipboard


                    Vassiliou, Vassilios, Kalogeropoulou, Christine, Christopoulos, Christos, Solomou, Ekaterini, Leotsinides, Michael, and Kardamakis, Dimitrios. Mon .  
        "Combination ibandronate and radiotherapy for the treatment of bone metastases: Clinical evaluation and radiologic assessment".  United States.  
        doi:10.1016/j.ijrobp.2006.08.022.

Copy to clipboard


                    
@article{osti_20850324,

  title        = {Combination ibandronate and radiotherapy for the treatment of bone metastases: Clinical evaluation and radiologic assessment},

  author       = {Vassiliou, Vassilios and Kalogeropoulou, Christine and Christopoulos, Christos and Solomou, Ekaterini and Leotsinides, Michael and Kardamakis, Dimitrios},

  abstractNote = {Purpose: Ibandronate is a single-nitrogen, noncyclic bisphosphonate with proven efficacy for reducing metastatic bone pain. In this study, we assessed the palliative effects of combined ibandronate and radiotherapy. Methods and Materials: Forty-five patients with bone metastases from various solid tumors received external-beam radiotherapy, 30-40 Gy over 3-4.5, weeks combined with 10 cycles of monthly intravenous ibandronate, 6 mg. Results: After combined therapy, mean bone pain scores (graded from 0 to 10) were reduced from 6.3 at baseline to 0.8 after 3 months, with further reductions at later time points (all p < 0.001). Opioid use decreased from 84% of patients at baseline (38/45) to 24% (11/45) at 3 months, with further subsequent reductions (all p < 0.001). Mean performance status and functioning scores also significantly improved. Bone density (assessed by computed tomography scan) increased by 20% vs. baseline at 3 months, 46% at 6 months, and 73% at 10 months (all p < 0.001). Lesion improvement was also demonstrated by magnetic resonance imaging. Treatment was well tolerated with no renal toxicity. Conclusions: In this pilot study, combined radiotherapy and ibandronate provided substantial bone pain relief and increased bone density. Computed tomography-based or magnetic resonance imaging-based evaluations offer objective methods for assessing therapeutic outcomes.},

  doi          = {10.1016/j.ijrobp.2006.08.022},

  journal      = {International Journal of Radiation Oncology, Biology and Physics},

  number       = 1,

  volume       = 67,

  place        = {United States},

  year         = {Mon Jan 01 00:00:00 EST 2007},

  month        = {Mon Jan 01 00:00:00 EST 2007}

}

Copy to clipboard

Journal Article:

DOI: 10.1016/j.ijrobp.2006.08.022

Other availability

Find in Google Scholar

Search WorldCat to find libraries that may hold this journal

Save / Share:

Export Metadata

Save to My Library

Similar records in OSTI.GOV collections:

Update of the International Consensus on Palliative Radiotherapy Endpoints for Future Clinical Trials in Bone Metastases

Journal Article Chow, Edward, E-mail: Edward.Chow@sunnybrook.ca ; Hoskin, Peter ; Mitera, Gunita ; ... - International Journal of Radiation Oncology, Biology and Physics

Purpose: To update the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases by surveying international experts regarding previous uncertainties within the 2002 consensus, changes that may be necessary based on practice pattern changes and research findings since that time. Methods and Materials: A two-phase survey was used to determine revisions and new additions to the 2002 consensus. A total of 49 experts from the American Society for Radiation Oncology, the European Society for Therapeutic Radiology and Oncology, the Faculty of Radiation Oncology of the Royal Australian and New Zealand College of Radiologists, and the Canadianmore »« less
DOI: 10.1016/J.IJROBP.2011.02.008
Prospective multicenter study of combined treatment with chemotherapy and radiotherapy in breast cancer women with the rare clinical scenario of ipsilateral supraclavicular node recurrence without distant metastases

Journal Article Pergolizzi, Stefano ; Adamo, Vincenzo ; Russi, Elvio ; ... - International Journal of Radiation Oncology, Biology and Physics

Purpose: To evaluate the role of chemotherapy combined with curative radiotherapy in breast cancer patients who presented with recurrent ipsilateral supraclavicular lymph node metastases (ISLM) without 'nonregional disease,' we designed an observational study performed prospectively. Patients and Methods: Forty-four consecutive patients with ISLM from breast cancer as part of recurrent regional disease without distant metastases were included in this study. All patients received chemotherapy with doxorubicin-based schema or paclitaxel for six courses and curative radiotherapy (60 Gy/30 fractions of 2 Gy/5 days a week). An 'involved field' radiation was delivered during the interval between the third and fourth chemotherapy course;more »« less
DOI: 10.1016/J.IJROBP.2005.1
Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases

Journal Article Lindvall, Peter ; Bergstroem, Per ; Loefroth, Per-Olov ; ... - International Journal of Radiation Oncology, Biology and Physics

Purpose: The aim was to evaluate treatment of cerebral metastases with hypofractionated conformal stereotactic radiotherapy (HCSRT) or whole-brain radiotherapy (WBRT) in combination with a stereotactic boost. Methods and Materials: Forty-seven patients were treated with HCSRT and 14 patients with WBRT in combination with a stereotactic boost. Radiation doses were 40 Gy (5 fractions) in HCSRT or 30 Gy (WBRT) combined with a mean dose of 17 Gy stereotactically (1-3 fractions). Results: The median survival time in the HCSRT as well as the WBRT group was 5.0 months, and 87% died of extracranial disease. Radiologic follow-up (mean, 3.7 months after treatment)more »« less
DOI: 10.1016/j.ijrobp.2004.08.027
Clinical Outcomes of Stereotactic Body Radiotherapy for Small Lung Lesions Clinically Diagnosed as Primary Lung Cancer on Radiologic Examination

Journal Article Inoue, Tetsuya ; Shimizu, Shinichi ; Onimaru, Rikiya ; ... - International Journal of Radiation Oncology, Biology and Physics

Purpose: Image-guided biopsy occasionally fails to diagnose small lung lesions, which are highly suggestive of primary lung cancer. The aim of the present study was to evaluate the outcome of stereotactic body radiotherapy (SBRT) for small lung lesions that were clinically diagnosed as primary lung cancer without pathologic confirmation. Methods and Materials: A total of 115 patients were treated with SBRT in 12 institutions. Tumor size ranged from 5 to 45 mm in diameter, with a median of 20 mm. Results: The 3-year and 5-year overall survival rates for patients with a tumor size <=20 mm in diameter (n =more »« less
DOI: 10.1016/j.ijrobp.2008.11.026
Protracted Hypofractionated Radiotherapy for Graves' Ophthalmopathy: A Pilot Study of Clinical and Radiologic Response

Journal Article Casimiro de Deus Cardoso, Cejana ; Giordani, Adelmo Jose ; Borri Wolosker, Angela Maria ; ... - International Journal of Radiation Oncology, Biology and Physics

Purpose: To evaluate the clinical and radiologic response of patients with Graves' ophthalmopathy given low-dose orbital radiotherapy (RT) with a protracted fractionation. Methods and Materials: Eighteen patients (36 orbits) received orbital RT with a total dose of 10 Gy, fractionated in 1 Gy once a week over 10 weeks. Of these, 9 patients received steroid therapy as well. Patients were evaluated clinically and radiologically at 6 months after treatment. Clinical response assessment was carried out using three criteria: by physical examination, by a modified clinical activity score, and by a verbal questionnaire considering the 10 most common signs and symptomsmore »« less
DOI: 10.1016/J.IJROBP.2010.09.015

Similar Records